Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
R Bowser, MR Turner, J Shefner - Nature reviews. Neurology, 2011 - europepmc.org
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …
[引用][C] Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
R BOWSER - Nat Rev Neurol, 2011 - cir.nii.ac.jp
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
R Bowser, M Turner, J Shefner - Nature reviews. Neurology, 2011 - ora.ox.ac.uk
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
R Bowser, MR Turner, J Shefner - Nature reviews …, 2011 - pubmed.ncbi.nlm.nih.gov
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
R Bowser, MR Turner, J Shefner - Nature Reviews. Neurology, 2011 - search.proquest.com
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …
Biomarkers In Amyotrophic Lateral Sclerosis: Opportunities And Limitations
R Bowser, MR Turner, J Shefner - Nature Reviews …, 2011 - scholar.barrowneuro.org
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …
[PDF][PDF] Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
R Bowser, MR Turner, J Shefner - 2011 - researchgate.net
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
R Bowser, MR Turner, J Shefner - Nature Reviews Neurology, 2011 - nature.com
Research into amyotrophic lateral sclerosis (ALS) has improved our understanding of the
molecular mechanisms underlying disease pathogenesis, but diagnosis of patients with ALS …
molecular mechanisms underlying disease pathogenesis, but diagnosis of patients with ALS …
[PDF][PDF] Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
R Bowser, MR Turner, J Shefner - 2011 - academia.edu
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …
predominantly on the study of postmortem tissue. Modern technology has improved the …